Lamotrigine-induced vanishing bile duct syndrome in a child

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 6, 2012, Pages e147-e148

  Bhayana, Harsh ^a   Appasani, Sreekanth ^a   Thapa, B R ^a   Das, Ashim ^a   Singh, Kartar ^a  

^a Division of Pediatric Gastroenterology Hepatology and Nutrition   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CYTOKERATIN 19; CYTOKERATIN 7; LAMOTRIGINE; PREDNISOLONE; URSODEOXYCHOLIC ACID;

ARTICLE; BILE DUCT DISEASE; CASE REPORT; CHILD; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FOCAL EPILEPSY; HEPATOMEGALY; HUMAN; HYPERBILIRUBINEMIA; HYPERPIGMENTATION; JAUNDICE; LIVER BIOPSY; MALE; PRIORITY JOURNAL; PRURITUS; RASH; SCHOOL CHILD; TOXIC HEPATITIS; TREATMENT RESPONSE; VANISHING BILE DUCT SYNDROME; VITAMIN SUPPLEMENTATION;

ANTICONVULSANTS; BILE DUCT DISEASES; BILE DUCTS; CHILD; CHOLESTASIS; DRUG-INDUCED LIVER INJURY; HUMANS; LIVER; MALE; TRIAZINES;

EID: 84870872467     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31823c2500     Document Type: Article

References (9)

1. Ouellet G, Tremblay L, Marleau D. Fulminant hepatitis induced by lamotrigine. South Med J 2009; 102:82-84.
2. Ludwig J, Wiessner RH, LaRusso NF. Idiopathic adulthood ductopenia: a cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 1987; 7:193-199.
3. Deggot C, Feldmann G, Larrey D, et al. Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology 1992; 15:244-251.
4. Karnsakul W, Arkachaisri T, Atisook K, et al. Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms. Ann Hepatol 2006; 5:116-119.
5. Desmet VJ. Vanishing bile duct syndrome in drug-induced liver disease. J Hepatol 1997; 26 (suppl 1):31-35.
6. Manuvel JC, Bloomer JR, Snover DC. Progressive bile duct injury after thiabendazole administration. Gastroenterology 1987; 93:245-249.
7. Turner IB, Ecstein RP, Riley JW, et al. Prolonged hepatic cholestasis after fluoxacillin therapy. Med J Aust 1989; 151:701-705.
8. Guebel AP, Sempoux CL. Drug and toxin-induced bile disorders. J Gastroenterol Hepatol 2000; 15:1232-1238.
9. Mecarelli O, Pulitano P, Mingoia M, et al. Acute hepatitis associated with lamotrignine and managed with the molecular adsorbents recirculating system (MARS). Epilepsia 2005; 46:1687-1689.